June 2019 newsletter
Therapeutic protein degradation by design Hot targets in drug discovery are constantly changing, paradigm shifts are a bit rarer. Protein ...
Martin Slater, Director of Cresset Discovery Services, presents a case study on a project where a customer was looking for new chemistry for assays they had booked with a biology CRO.
Delegates will hear how Boehringer Ingelheim, Broad Institute and Eli Lilly use Cresset tools and also receive an update from Cresset about new science and upcoming product development.
Over lunch delegates will have an opportunity to learn how to extract even more value from Forge and Spark, plus be introduced to additional tools.